Trimurthi Limited
BSE: TRIMURTHI
Prev Close
26.61
Open Price
26.61
Volume
550
Today Low / High
26.61 / 26.61
52 WK Low / High
24.15 / 26.61
Range
25 - 28
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 26.61, reflecting a change of 0 (0%). The expected target range on the BSE is 25 - 28. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.
Trimurthi Limited Graph
Trimurthi Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Trimurthi Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 26.61, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 26.61 | 26.88 | 24.19 - 29.56 |
| 27.14 | 21.71 - 32.57 | ||
| 27.41 | 19.19 - 35.63 | ||
| Bearish Scenario | 26.61 | 26.34 | 23.71 - 28.98 |
| 26.08 | 20.86 - 31.29 | ||
| 25.81 | 18.07 - 33.56 |
Overview of Trimurthi Limited
ISIN
INE314I01036
Industry
Medical - Pharmaceuticals
Vol.Avg
4,054
Market Cap
264,769,500
Last Dividend
0
Official Website
IPO Date
2009-03-25
DCF Diff
30.60
DCF
-4
Financial Ratios Every Investor Needs
Stock Dividend of TRIMURTHI
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2012-08-16 | August 16, 12 | 0.3 | 0.3 | |||
| 2011-09-22 | September 22, 11 | 0.3 | 0.3 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 30.73 Cr | 29.57 Cr | 1.16 Cr | 0.0378 | 0.00 Cr | 0.00 Cr | 1.09 Cr | 0.08 Cr | 0.09 | 0.16 Cr | 0.0027 |
| 2024-03-31 | 4.22 Cr | 3.84 Cr | 0.39 Cr | 0.0917 | 0.00 Cr | 0.08 Cr | -0.15 Cr | 0.01 Cr | 0.01 | -0.11 Cr | 0.0025 |
| 2023-03-31 | 1.40 Cr | 1.35 Cr | 0.05 Cr | 0.0373 | 0.00 Cr | 0.06 Cr | -0.57 Cr | -0.06 Cr | -0.07 | -0.52 Cr | -0.0427 |
| 2022-03-31 | 0.84 Cr | 0.81 Cr | 0.03 Cr | 0.0415 | 0.02 Cr | 0.05 Cr | -0.34 Cr | -1.56 Cr | -1.93 | -0.40 Cr | -1.8505 |
| 2021-03-31 | 9.24 Cr | 8.56 Cr | 0.68 Cr | 0.0737 | 0.00 Cr | 0.15 Cr | -1.04 Cr | -3.76 Cr | -4.65 | -3.49 Cr | -0.4073 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 0.68 Cr | 27.21 Cr | 9.67 Cr | 17.5393 Cr | 0.00 Cr | -0.68 Cr | 0.84 Cr | 0.19 Cr | 0.00 Cr | 0.00 Cr | 0.04 Cr | 9.6672 Cr |
| 2024-03-31 | 0.12 Cr | 7.36 Cr | 0.01 Cr | 7.3548 Cr | 0.00 Cr | -0.12 Cr | 1.19 Cr | 0.12 Cr | 0.00 Cr | 0.00 Cr | 0.56 Cr | 0.0101 Cr |
| 2023-03-31 | 0.27 Cr | 7.26 Cr | 0.06 Cr | 7.1951 Cr | 0.00 Cr | -0.27 Cr | 0.82 Cr | 0.17 Cr | 0.00 Cr | 0.00 Cr | 2.78 Cr | 0.0616 Cr |
| 2022-03-31 | 2.60 Cr | 7.25 Cr | 0.01 Cr | 7.2431 Cr | 0.16 Cr | -2.44 Cr | 0.53 Cr | 0.23 Cr | 0.00 Cr | 0.00 Cr | 2.33 Cr | 0.0082 Cr |
| 2021-03-31 | 2.08 Cr | 9.57 Cr | 2.21 Cr | 6.8646 Cr | 0.00 Cr | -2.08 Cr | 0.93 Cr | 0.26 Cr | 0.00 Cr | 0.00 Cr | 0.14 Cr | 2.1750 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -13.6845 Cr | 2.9304 Cr | 11.3150 Cr | -13.7906 Cr | 0.5609 Cr | 0.6787 Cr | -0.1061 Cr | 0.0845 Cr | 0.0000 Cr | 0.0000 Cr | 0.3512 Cr |
| 2024-03-31 | -0.3435 Cr | 0.1866 Cr | 0.0000 Cr | -0.3435 Cr | -0.1569 Cr | 0.1178 Cr | 0.0000 Cr | 0.0104 Cr | 0.0000 Cr | 0.0000 Cr | -0.3739 Cr |
| 2023-03-31 | -2.4053 Cr | 0.0751 Cr | 0.0000 Cr | -2.4097 Cr | -2.3302 Cr | 0.2747 Cr | -0.0044 Cr | -0.0599 Cr | 0.0000 Cr | 0.0000 Cr | -0.2886 Cr |
| 2022-03-31 | 0.5930 Cr | 0.2751 Cr | 0.0000 Cr | -1.2718 Cr | 0.8681 Cr | 2.6049 Cr | -1.8648 Cr | -1.5658 Cr | 0.0000 Cr | 0.0000 Cr | -0.2837 Cr |
| 2021-03-31 | 1.5929 Cr | 0.1360 Cr | -0.7672 Cr | 1.5634 Cr | 0.9618 Cr | 2.0796 Cr | -0.0295 Cr | -3.7267 Cr | -0.7672 Cr | 0.0000 Cr | -0.0197 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 5.30 Cr | 5.02 Cr | 0.28 Cr | 0.0524 | 0.13 Cr | 0.15 Cr | 0.15 | 0.13 Cr | 0.0279 |
| 2024-09-30 | 3.96 Cr | 3.48 Cr | 0.47 Cr | 0.1198 | 0.21 Cr | 0.13 Cr | 0.16 | 0.14 Cr | 0.0327 |
| 2024-06-30 | 0.60 Cr | 0.83 Cr | -0.23 Cr | -0.3751 | -0.44 Cr | -0.35 Cr | -0.43 | -0.34 Cr | -0.5888 |
| 2024-03-31 | 0.84 Cr | 0.57 Cr | 0.28 Cr | 0.3294 | 0.15 Cr | 0.28 Cr | 0.34 | 0.11 Cr | 0.3282 |
| 2023-12-31 | 0.50 Cr | 0.46 Cr | 0.04 Cr | 0.0752 | -0.12 Cr | -0.03 Cr | -0.04 | -0.02 Cr | -0.0595 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 0.15 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -8.98 Cr |
| 2024-09-30 | 0.15 Cr | 0.22 Cr | 0.38 Cr | 11.33 Cr | 0.32 Cr | 12.03 Cr | 0.11 Cr | 12.22 Cr | 3.24 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 0.12 Cr | 0.00 Cr | 0.00 Cr | 0.12 Cr | 0.00 Cr | 0.00 Cr | -7.35 Cr |
| 2024-03-31 | 0.12 Cr | 2.50 Cr | 2.62 Cr | 0.01 Cr | 1.19 Cr | 4.13 Cr | 0.12 Cr | 7.36 Cr | 0.01 Cr |
| 2023-12-31 | -2.52 Cr | 5.04 Cr | 2.52 Cr | 0.00 Cr | 0.00 Cr | 2.52 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 0.15 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 0.13 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | -0.35 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 0.28 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | -0.03 Cr | -0.03 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -0.03 Cr | 0.00 Cr | 0.00 Cr | -0.03 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2010-10-04 | October 04, 10 | 1:10 |
| 2009-10-15 | October 15, 09 | 10:1 |
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹821.25 | ₹98,339,283,675.00 | ₹72,992.00 |
Key Executives
Gender: female
Year Born: 1994
Gender: male
Year Born: 1969
Gender: female
Year Born:
Gender: Not Specified
Year Born: 1988
FAQs about Trimurthi Limited
The CEO is Nishita Kalantri.
The current price is ₹26.61.
The range is ₹24.15-26.61.
The market capitalization is ₹26.48 crores.
The P/E ratio is 131.12.
The company operates in the Healthcare sector.
Overview of Trimurthi Limited (ISIN: INE314I01036) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹26.48 crores and an average daily volume of 4,054 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.